Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

280.21 USD -1.50 (-0.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Friday Of The Heavy Week
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
Notable Friday Option Activity: PLT, BIIB, MSFT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Plantronics, Inc. (PLT), where a total volume of 4,190 contracts has been traded... 
Tags Stocks
From Market News Video
Biogen's Retinal Disease Gene Therapy Flunks Mid-Stage Study
Biogen Inc(NASDAQ:BIIB)has announced topline resultsfrom the Phase2/3 XIRIUS studyevaluating ... 
Tags Benzinga Retinal Disease News
From Benzinga
Biogen Buys Acute Ischemic Stroke Candidate For One-Time Payment Of $18M
Biogen Inc(NASDAQ:BIIB)has exercised its option to acquire TMS-007, an investigational drug for acute ischemic ... 
Tags BIIB Stroke Biotech
From Benzinga
Biogen, Capsigen Ink $1.3B AAV Capsids Development Pact For CNS & Neuromuscular Disorders
Biogen Inc(NASDAQ:BIIB) andCapsigen Inchaveentered into a strategic research collaborationto ... 
Tags Contracts General Briefs
From Benzinga
Unusual Options Activity Insight: Biogen
On Monday, shares of Biogen (NASDAQ:BIIB) saw unusual options activity. After the option alert, the stock price moved up to $275.74. ... 
Tags Options Market News BZI/UOA
From Benzinga
Some Prominent Doctors Continue to Shun Biogen's Alzheimer's Drug
Even if the FDA approves the drug, it could be hard to sell with key opinion leaders coming out against the therapy. 
Tags BIIB Market News
From Motley Fool
Notable Friday Option Activity: LOW, BIIB, CSCO
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Lowe's Companies Inc (LOW), where a total of 27,921 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
5 Stocks to Sell in May
Just about every investor has heard the old standby "sell in May and go away" around this time of year. 
Tags Market News Pharma/Biotech Technology
From Blogs - TalkMarkets
This Warren Buffett Stock Could Be as Risky as Dogecoin
It might even be riskier than the popular cryptocurrency. 
Tags BRK/B RHHBY DOGE
From Motley Fool
Tesla, AMD And Amazon Lead The Nasdaq Lower Monday
U.S. indices were trading higher Monday as May trading begins and as investors await earnings reports this week. However, the Nasdaq ... 
Tags After/Hours Center Movers Benzinga
From Benzinga
10.9% of VLUE Holdings Seeing Recent Insider Buys
A look at the weighted underlying holdings of the iShares MSCI USA Value Factor ETF (VLUE) shows an impressive 10.9% of holdings on a weighted basis have experienced insider buying within the past six... 
Tags ETFs
From ETF Channel
Denali-Biogen Parkinson's Disease Candidate Shows Reductions In Biomarkers; Late Study To Begin By 2021 End
Denali Therapeutics Inc(NASDAQ:DNLI) hasannounced final resultsfrom Phase 1 and Phase 1b studies evaluating ... 
Tags BIIB Parkinson’s Disease Biotech
From Benzinga
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MMSI DBTX EVLO
From Benzinga
Noteworthy Monday Option Activity: ALKS, BIIB, CASA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alkermes plc (ALKS), where a total of 7,525 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Price Over Earnings Overview: Biogen
In the current market session, Biogen Inc. (NASDAQ:BIIB) is trading at $261.24, after a 0.86% gain. However, over ... 
Tags Earnings Benzinga BZI/PE
From Benzinga
Alzheimer's Disease: 5 Stocks on Biotech Radars
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other... 
Tags Market News Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Biogen Inc (BIIB) Q1 2021 Earnings Call Transcript
BIIB earnings call for the period ending March 31, 2021. 
Tags Market News BIIB
From Motley Fool
Biogen's Shares Are Trading Lower On 71% Quarterly Profit Slump, Weak Tecfidera Sales
Biogen Inc reported a 70.7% fall in Q1 profit as its top-selling multiple sclerosis drug Tecfidera faced increased competition from cheaper generic drugs. 
Tags Market News Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Biogen talks up approval plans for controversial Alzheimer’s drug as it nears FDA decision
Biogen Inc.'s first-quarter earnings beat expectations, but investors may be paying more attention to the latest information the company is sharing about its plans for aducanumab, the experimental... 
Tags SPX JP:4523 BIIB
From MarketWatch
Biogen's Shares Are Trading Lower On 71% Quarterly Profit Slump, Weak Tecfidera Sales
Biogen Inc(NASDAQ:BIIB) reported a 70.7% fall inQ1 profitas its top-selling multiple sclerosis drug Tecfidera ... 
Tags Market News Earnings Guidance
From Benzinga
Nasdaq 100 Movers: MU, OKTA
In early trading on Thursday, shares of Okta topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.5%. Year to date, Okta registers a 11.7% gain. 
Tags Stocks
From Market News Video
Why Biogen's Better-Than-Expected Q1 Results Weren't Good Enough
It's partially because expectations weren't very high in the first place. 
Tags RHHBY BIIB Market News
From Motley Fool
Biogen Tops First-Quarter Expectations And Boosts Earnings Outlook
Biogen stock rose on Thursday after the biotech company reported adjusted earnings of $5.34 per share on $2.69 billion in sales for the first quarter. 
From Investor's Business Daily
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GRTX EVFM ZBH
From Benzinga
Recap: Biogen Q1 Earnings
Shares of Biogen (NASDAQ:BIIB) moved higher by 1.4% in pre-market trading after the company reported Q1 results. Quarterly ... 
Tags Market News BIIB News
From Benzinga
Stock futures struggle for direction ahead of jobless claims data
Stock-index futures hover on either side of unchanged as investors dig through a heavy round of corporate earnings and await the latest round of weekly data on jobless claims. 
Tags WHR XM ALK
From MarketWatch
Earnings Scheduled For April 22, 2021
Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ:FRBK) is estimated to report quarterly earnings ... 
Tags ASB AUB POOL
From Benzinga
Does Biogen Stand A Chance Of Topping Bearish First-Quarter Views?
Biogen stock could enjoy some upside if it outperforms Wall Street's bearish expectations for steep declines in first-quarter sales and earnings. Earnings are set for early Thursday. 
From Investor's Business Daily
A Preview Of Biogen's Earnings
Biogen (NASDAQ:BIIB) unveils its next round of earnings this Thursday, April 22. Here is Benzinga's everything-that-matters guide ... 
Tags BIIB Market News BZI/EP
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.